Skip to main content

Two big drug flops show how healthcare economics have changed

By Bloomberg  
   January 10, 2020

For years, drug companies have enjoyed the freedom to charge high prices for their latest products. But when Sanofi and Amgen Inc. each marketed a powerful new cholesterol-lowering medicine, something surprising happened: High prices hurt sales. Sanofi’s experience has been especially painful.

Full story

Get the latest on healthcare leadership in your inbox.